Spectrum Pharmaceuticals, Inc. to Present Corporate Update at Rodman & Renshaw Annual Global Investment Conference in New York City on September 10th and at Morgan Stanley Global Healthcare Conference in New York City on September 11th

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the Rodman & Renshaw Annual Global Investment Conference being held at The Waldorf-Astoria in New York City. The Company presentation is on Monday, September 10, 2012, at 11:15 AM ET.